Skip to main content
. 2018 Jan 8;8:37. doi: 10.1038/s41598-017-18280-3

Figure 1.

Figure 1

(A) Examination of the relative expression level of long non-coding RNA (lncRNA) CASC9.5 in 40 lung adenocarcinoma specimens and paracancerous tissue samples using fluorescence-based quantitative polymerase chain reaction (qRT-PCR). (BD) lncRNA CASC9.5 was highly expressed in lung adenocarcinomas that had reached a large volume, were in advanced clinical stages or had undergone lymph node metastasis. (E) Survival analysis demonstrated that patients with high expression of lncRNA CASC9.5 suffered a poorer prognosis. *p < 0.05, **p < 0.01.